Project Grant HT94252310363
Award Date
6/1/23
Completion Date
5/31/26
Dollars Obligated
$745K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Richmond, VA 23284, USA
Similar Awards
The Department of Defense's Defense Health Agency awarded a $623,003 Project Grant to Virginia Commonwealth University (VCU) under the Military Medical Research and Development program (CFDA 12.420). The grant, which runs from May 1, 2024 to April 30, 2027, will fund a longitudinal study to characterize the genetic architecture and risk factors for post-concussive symptoms, post-traumatic stress disorder, and alcohol use disorder in a military cohort. VCU has subawarded a portion of the grant to...
The Defense Health Agency has awarded a $860,998.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The funding will support a 3-year research project focused on "NEUROPHYSIOLOGY OF POST-TRAUMATIC EPILEPSY: UNRAVELING EPILEPTOGENESIS SIGNALS BIOMARKERS", with a performance period from April 1, 2025 to March 31, 2028. The research aims to advance the scientific...
Virginia Commonwealth University was awarded a $749,446 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from September 2023 through September 2026 to develop a novel TNF inhibitor to improve outcomes in a mouse model of traumatic brain injury. Through supporting innovative biomedical research, the Military Medical Research and Development program aims to transform military and...
The Defense Health Agency awarded a $3,995,791 project grant to Virginia Commonwealth University under the Military Medical Research and Development program (CFDA 12.420) to compare the attentional demands and functional outcomes of pattern recognition and direct myoelectric control in people with transradial amputation. VCU will conduct this research from September 2023 through September 2027 in Richmond, Virginia. Two subawards were also provided. Hanger Institute for Clinical Research and...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $751,038 to Virginia Commonwealth University (VCU) to conduct research on the use of ketone ester intravenous infusion as a new treatment for traumatic brain injury. The award period runs from September 30, 2024 to September 29, 2027. VCU, a public research university in Richmond, Virginia, has extensive experience supporting federal healthcare and biomedical...
This $5,954,349 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program will support a randomized controlled trial to optimize heart rate variability in combat veterans and service members with persistent post-concussion symptoms. The prime awardee, Virginia Commonwealth University, will collaborate with sub-awardees Palo Alto Veterans Institute For Research and Richmond Institute For Veterans Research to conduct this...
The University of Cincinnati Sponsored Research Services Division was awarded an $817,296 project grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support research on spreading depolarizations as a predictive biomarker of post-traumatic epilepsy from June 1, 2023 through May 31, 2026. The Military Medical Research and Development program aims to transform military and public health through innovative medical research...
The University of Virginia received a three-year, $775,153 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research investigating TBI-induced disruption of brain drainage as a mechanistic driver of AD pathogenesis. Through this award, the University will support basic, applied, and advanced biomedical research aimed at transforming military and public health care by investigating medical solutions...
This federal Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) provides $249,732 in funding to Virginia Commonwealth University (VCU) for research on novel kappa opioid receptor (KOR) agonists and their potential to promote central nervous system (CNS) repair. The award, which runs from September 1, 2024 to August 31, 2025, will enable VCU to conduct research aimed at developing effective treatments for...
The University of Virginia will receive $238,794 from the Defense Health Agency under a Project Grant award to investigate the mechanisms of seizure-induced death in TSC model mice. The research, to be conducted from June 2023 through May 2025 in Charlottesville, Virginia, aims to further the Military Medical Research and Development program's goal of transforming military and public health through innovative biomedical research solutions. Specifically, the grant will fund the university's...